FRANKLIN LAKES, N.J., July 26 /PRNewswire-FirstCall/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today. Mr. Jones, 55, is the former Chief Executive Officer of JWT Worldwide (previously known as J. Walter Thompson), one of the world’s largest advertising …
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research